Pregabalin I.P. 75mg + Duloxetine HCL I.P. 20mg Capsule in PCD pharma franchise in Hyderabad

Pregabalin I.P. 75mg + Duloxetine HCL I.P. 20mg Capsule in pharmaceutical manufacturing company in Mumbai

Pregabalin I.P. 75mg + Duloxetine HCL I.P. 20mg Capsule in neuropathic pain pharma franchise in Pune

Pregabalin I.P. 75mg + Duloxetine HCL I.P. 20mg Capsule in pharma suppliers in Delhi

Pregabalin I.P. 75mg + Duloxetine HCL I.P. 20mg Capsule in pharma export companies in Kolkata
Pregabalin I.P. 75mg + Duloxetine HCL I.P. 20mg Capsule in pharma franchise opportunities in Bengaluru

Home/Products /pregabalin-i-point-p-point-5mg-duloxetine-hcl-i-point-p-point-20mg

Pregahike D 75 20 Capsule

Composition : Pregabalin I.P. 75mg + Duloxetine HCL I.P. 20mg

Dosage Form : Caspsule

Packaging Type : Alu Alu

Packaging : 10x10

Price : ₹205/-

Pregahike D 75/20 Capsule is a powerful combination medication designed to address neuropathic pain, fibromyalgia, and mood-related disorders by leveraging the complementary actions of Pregabalin and Duloxetine. Pregabalin is an antiepileptic and neuropathic pain reliever that works by calming overactive nerve signals in the brain, thereby reducing pain and seizure activity. Duloxetine, a serotonin-norepinephrine reuptake inhibitor (SNRI), is an effective antidepressant known for modulating chemical imbalances in the brain, helping to relieve both depression and anxiety, while also reducing pain perception.

Together, this dual-action therapy offers a comprehensive solution for conditions such as diabetic neuropathy, fibromyalgia, chronic musculoskeletal pain, and generalized anxiety disorder. It is especially effective in treating nerve-related pain that does not respond adequately to conventional analgesics alone. Duloxetine contributes additional benefits by improving mood and emotional balance, which are often impacted by chronic pain conditions.

Pregahike D 75/20 Capsule is typically recommended when monotherapy with either Pregabalin or Duloxetine alone fails to provide sufficient relief. The formulation supports better quality of life by addressing both the physical and psychological dimensions of chronic pain disorders. It should be used under strict medical supervision to monitor efficacy and minimize potential adverse effects.

Read More

About the Product

Pregahike D 75/20 Capsule is a powerful combination medication designed to address neuropathic pain, fibromyalgia, and mood-related disorders by leveraging the complementary actions of Pregabalin and Duloxetine. Pregabalin is an antiepileptic and neuropathic pain reliever that works by calming overactive nerve signals in the brain, thereby reducing pain and seizure activity. Duloxetine, a serotonin-norepinephrine reuptake inhibitor (SNRI), is an effective antidepressant known for modulating chemical imbalances in the brain, helping to relieve both depression and anxiety, while also reducing pain perception.

Together, this dual-action therapy offers a comprehensive solution for conditions such as diabetic neuropathy, fibromyalgia, chronic musculoskeletal pain, and generalized anxiety disorder. It is especially effective in treating nerve-related pain that does not respond adequately to conventional analgesics alone. Duloxetine contributes additional benefits by improving mood and emotional balance, which are often impacted by chronic pain conditions.

Pregahike D 75/20 Capsule is typically recommended when monotherapy with either Pregabalin or Duloxetine alone fails to provide sufficient relief. The formulation supports better quality of life by addressing both the physical and psychological dimensions of chronic pain disorders. It should be used under strict medical supervision to monitor efficacy and minimize potential adverse effects.

Common side effects may include dizziness, dry mouth, sleepiness, constipation, fatigue, increased appetite, and nausea. Seek immediate medical attention if severe mood changes or allergic reactions occur.

Indicated for the treatment of neuropathic pain, fibromyalgia, generalized anxiety disorder, and major depressive disorder.

To be taken only under medical supervision. Avoid abrupt discontinuation without consulting a physician.

Store in a cool, dry place, protected from direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation